BR9809848A - Composição - Google Patents

Composição

Info

Publication number
BR9809848A
BR9809848A BR9809848-9A BR9809848A BR9809848A BR 9809848 A BR9809848 A BR 9809848A BR 9809848 A BR9809848 A BR 9809848A BR 9809848 A BR9809848 A BR 9809848A
Authority
BR
Brazil
Prior art keywords
composition
compositions
modulating
alpha
directed
Prior art date
Application number
BR9809848-9A
Other languages
English (en)
Portuguese (pt)
Inventor
Joseph S Podolski
Original Assignee
Zonagen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zonagen Inc filed Critical Zonagen Inc
Publication of BR9809848A publication Critical patent/BR9809848A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
BR9809848-9A 1997-05-19 1998-05-19 Composição BR9809848A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4994797P 1997-05-19 1997-05-19
PCT/US1998/010230 WO1998052569A1 (en) 1997-05-19 1998-05-19 Combination therapy for modulating the human sexual response

Publications (1)

Publication Number Publication Date
BR9809848A true BR9809848A (pt) 2000-06-27

Family

ID=21962609

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9809848-9A BR9809848A (pt) 1997-05-19 1998-05-19 Composição

Country Status (16)

Country Link
EP (1) EP0996447B1 (enExample)
JP (2) JP4588809B2 (enExample)
KR (1) KR20010012721A (enExample)
CN (1) CN1262622A (enExample)
AT (1) ATE333279T1 (enExample)
AU (1) AU749703B2 (enExample)
BR (1) BR9809848A (enExample)
CA (1) CA2291160C (enExample)
DE (1) DE69835288T2 (enExample)
DK (1) DK0996447T3 (enExample)
ES (1) ES2270517T3 (enExample)
IL (2) IL132853A0 (enExample)
NO (1) NO322079B1 (enExample)
NZ (1) NZ500921A (enExample)
PT (1) PT996447E (enExample)
WO (1) WO1998052569A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6469065B1 (en) 1996-02-02 2002-10-22 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist, compositions and methods of use
US6331543B1 (en) 1996-11-01 2001-12-18 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
US6011043A (en) * 1998-06-19 2000-01-04 Schering Corporation Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction
DE19834507A1 (de) * 1998-07-31 2000-02-03 Hexal Ag Pharmazeutische, wasserlösliche Tablettenformulierung zur Anwendung von Sildenafil
DE19834506A1 (de) * 1998-07-31 2000-02-03 Hexal Ag Transmucosales therapeutisches System zur Anwendung von Sildenafil
US6482426B1 (en) * 1998-09-17 2002-11-19 Zonagen, Inc. Compositions for the treatment of male erectile dysfunction
CA2251255A1 (en) * 1998-10-20 2000-04-20 Mcgill University The use of dopaminergic agents in the management of sexual dysfunction
US6087362A (en) * 1999-03-16 2000-07-11 Pentech Pharmaceuticals, Inc. Apomorphine and sildenafil composition
CN1374861A (zh) * 1999-04-06 2002-10-16 佐纳根有限公司 调节人的性反应的方法
WO2001008659A1 (en) * 1999-07-30 2001-02-08 Lakefield Minerals Ltd. Pharmaceutical compositions for topical application to treat erectile dysfunction
KR100344198B1 (ko) * 1999-10-08 2002-07-19 일양약품주식회사 실데나필 시트레이트의 속효제형
TWI265925B (en) 1999-10-11 2006-11-11 Pfizer Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them
KR20020020536A (ko) * 2000-09-09 2002-03-15 장우영 발기유발제
WO2009152344A2 (en) * 2008-06-11 2009-12-17 Comgenrx, Inc. Combination therapy using phosphodiesterase inhibitors
US7678078B1 (en) 2008-10-21 2010-03-16 KMG Pharma LLC Intravitreal injection device, system and method
GB201221032D0 (en) * 2012-11-22 2013-01-09 Mens Health Ltd Method of treatment

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4742054A (en) * 1982-11-23 1988-05-03 Naftchi Nosrat E Treatment of mammals suffering from damage to the central nervous system
ZA878182B (en) * 1986-11-05 1988-05-02 Merrell Dow Pharmaceuticals Inc. Enhancement of prazosin
FR2649613B1 (fr) * 1989-07-11 1991-09-27 Virag Ronald Medicament vaso-actif
FR2680106B1 (fr) * 1991-08-09 1994-03-11 Corbiere Gerome Procede de realisation de formes pharmaceutiques stables d'un derive d'ergoline et les compositions pharmaceutiques ainsi obtenues.
US5565466A (en) * 1993-08-13 1996-10-15 Zonagen, Inc. Methods for modulating the human sexual response
ES2143049T3 (es) * 1994-04-22 2000-05-01 Pentech Pharmaceuticals Inc Formas sublinguales de dosificacion que contienen apomorfina y su uso para el tratamiento de la disfuncion erectil.
CN1113757A (zh) * 1994-06-24 1995-12-27 王儒新 一种性功能促进剂及其制备方法
US5731339A (en) * 1995-04-28 1998-03-24 Zonagen, Inc. Methods and formulations for modulating the human sexual response
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
JPH09110674A (ja) * 1995-10-16 1997-04-28 Kao Corp 浴用剤組成物

Also Published As

Publication number Publication date
HK1028197A1 (en) 2001-02-09
WO1998052569A1 (en) 1998-11-26
CA2291160A1 (en) 1998-11-26
KR20010012721A (ko) 2001-02-26
DE69835288T2 (de) 2007-07-19
NO995657D0 (no) 1999-11-18
NZ500921A (en) 2002-11-26
AU7498098A (en) 1998-12-11
PT996447E (pt) 2006-12-29
ATE333279T1 (de) 2006-08-15
IL132853A0 (en) 2001-03-19
DK0996447T3 (da) 2006-11-13
AU749703B2 (en) 2002-07-04
CN1262622A (zh) 2000-08-09
JP2001526686A (ja) 2001-12-18
JP2009280621A (ja) 2009-12-03
EP0996447B1 (en) 2006-07-19
NO322079B1 (no) 2006-08-14
NO995657L (no) 2000-01-18
DE69835288D1 (de) 2006-08-31
IL132853A (en) 2010-04-15
EP0996447A1 (en) 2000-05-03
ES2270517T3 (es) 2007-04-01
CA2291160C (en) 2008-10-28
JP4588809B2 (ja) 2010-12-01

Similar Documents

Publication Publication Date Title
BR9809848A (pt) Composição
EA200200208A1 (ru) Синергитическая композиция
ES2170252T3 (es) Tetrahidroimidazopiridoindoldionas como inhibidores de cgmp especifico pde.
DE69532162D1 (de) Cannabinoid-rezeptor-antagonisten
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
DE69926806D1 (de) N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
YU49315B (sh) Inhibitor protein kinaze c, njegove farmaceutske formulacije i postupak za dobijanje
ES2133807T3 (es) Compuestos de peptidilo y su uso terapeutico como inhibidores de metaloproteasas.
DE69926919D1 (de) N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
DK1000035T3 (da) Substituerede 6-phenylphenanthridiner
DE69840603D1 (de) Alpha-ketoamidhaltige multikatalytische protease inhibitoren
DE60121461D1 (de) Kondensierte pyridoindolderivate
DE60112306D1 (de) Kondensierte pyrazindionderivate als pde5 inhibitore
EA200200207A1 (ru) Применение антагонистов cgrp и ингибиторов высвобождения cgrp для устранения приливов в период менопаузы
ATE203519T1 (de) Chinolinderivate als antimalariamittel
ES2180573T3 (es) Uso de derivados de indol como antagonistas de 5ht1.
SE9801494D0 (sv) Novel use
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
BG100248A (bg) Инхибитори на скваленсинтетаза
EA200601592A1 (ru) Фармацевтическая композиция, содержащая ингибитор pde4 или pde3/4 и антагонист гистаминового рецептора
NO20001548L (no) Endotelinantagonist og en renin-angiotensinsystem inhibitor som et kombinert preparat
DK0758312T3 (da) Substituerede fusionerede og broforbundne bicykliske forbindelser som terapeutiske midler
ES2155187T3 (es) Antagonistas biciclicos de taquicinas, preparacion de estos antagonistas y su utilizacion en compuestos farmaceuticos.
NO20005548D0 (no) Mykobakterieinhibitorer

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B25D Requested change of name of applicant approved

Owner name: REPROS THERAPEUTICS INC. (US)

Free format text: ALTERADO DE: ZONAGEN, INC.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 20A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]